이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

Auro Laboratories 관리

관리 기준 확인 1/4

현재 CEO에 대한 정보가 충분하지 않습니다.

주요 정보

Sharat Deorah

최고 경영자

₹5.3m

총 보상

CEO 급여 비율	100.0%
CEO 임기	35.2yrs
CEO 소유권	22.4%
경영진 평균 재임 기간	데이터 없음
이사회 평균 재임 기간	6.3yrs

최근 관리 업데이트

Recent updates

CEO 보상 분석

Sharat Deorah 의 보수는 Auro Laboratories 의 수익과 비교하여 어떻게 변경되었나요?
날짜	총 보상	급여	회사 수익
Mar 31 2024	₹5m	₹5m	₹78m
Dec 31 2023	n/a	n/a	₹72m
Sep 30 2023	n/a	n/a	₹48m
Jun 30 2023	n/a	n/a	₹31m
Mar 31 2023	₹4m	₹4m	₹24m
Dec 31 2022	n/a	n/a	₹11m
Sep 30 2022	n/a	n/a	₹14m
Jun 30 2022	n/a	n/a	₹19m
Mar 31 2022	₹12m	₹12m	₹28m
Dec 31 2021	n/a	n/a	₹39m
Sep 30 2021	n/a	n/a	₹53m
Jun 30 2021	n/a	n/a	₹69m
Mar 31 2021	₹12m	₹12m	₹72m
Dec 31 2020	n/a	n/a	₹61m
Sep 30 2020	₹6m	₹6m	₹51m
Jun 30 2020	n/a	n/a	₹43m
Mar 31 2020	n/a	n/a	₹41m
Dec 31 2019	n/a	n/a	₹52m
Sep 30 2019	n/a	n/a	₹55m
Jun 30 2019	n/a	n/a	₹49m
Mar 31 2019	₹6m	₹6m	₹44m
Dec 31 2018	n/a	n/a	₹37m
Sep 30 2018	n/a	n/a	₹36m
Jun 30 2018	n/a	n/a	₹37m
Mar 31 2018	₹5m	₹5m	₹35m

보상 대 시장: Sharat 의 총 보상 ($USD 62.87K )은 Indian 시장( $USD 38.49K ).

보상과 수익: Sharat 의 보상은 지난 1년 동안 20% 이상 증가했습니다.

CEO

Sharat Deorah (74 yo)

35.2yrs

테뉴어

₹5,250,000

보상

Mr. Sharat Sahadeolal Deorah, B.Com. serves as the Managing Director and Executive Chairman of the Board at Auro Laboratories Limited. He serves as Director since May 26, 1989 at Auro Laboratories Limited....

이사회 구성원

이름	위치	테뉴어	보상	소유권
Sharat Deorah	Executive Chairman & MD	35.2yrs	₹5.25m	22.38% ₹ 272.0m
Siddhartha Deorah	Whole Time Director	24.9yrs	₹5.25m	7.15% ₹ 86.9m
Kiran Kulkarni	Additional Whole Time Director	3.2yrs	₹2.25m	0.00016% ₹ 1.9k
Kavita Sharma	Non-Executive Independent Director	9.3yrs	₹11.00k	데이터 없음
Vishal Jhunjhunwala	Non-Executive Independent Director	less than a year	₹6.00k	데이터 없음
Mahendra Daga	Additional Non-Executive Independent Director	less than a year	데이터 없음	데이터 없음

6.3yrs

평균 재임 기간

53.5yo

평균 연령

경험이 풍부한 이사회: 530233 의 이사회는 경험(평균 재직 기간 6.2 년)으로 간주됩니다.

Auro Laboratories 관리

관리 기준 확인 1/4

주요 정보

최근 관리 업데이트

Less than half of directors are independent

Auro Laboratories Limited Appoints Shaan Jain as Chief Financial Officer

Auro Laboratories Limited Announces the Resignation of Amit Mahipat Shah as Chief Financial Officer, Effective October 1, 2023

Auro Laboratories Limited Appoints Vishal Kailashchandra Jhunjhunwala as an Non-Executive & Independent Director

Less than half of directors are independent

Auro Laboratories Limited, Annual General Meeting, Sep 23, 2023

Recent updates

Investor sentiment deteriorates as stock falls 17%

Full year 2024 earnings released: EPS: ₹12.50 (vs ₹3.92 in FY 2023)

Auro Laboratories Limited to Report Q4, 2024 Results on May 25, 2024

Investor sentiment improves as stock rises 26%

Less than half of directors are independent

Investor sentiment improves as stock rises 15%

Third quarter 2024 earnings released: EPS: ₹4.39 (vs ₹0.59 in 3Q 2023)

Auro Laboratories Limited to Report Q3, 2024 Results on Feb 06, 2024

Investor sentiment improves as stock rises 21%

Auro Laboratories Limited Appoints Shaan Jain as Chief Financial Officer

Investor sentiment improves as stock rises 23%

Second quarter 2024 earnings released: EPS: ₹3.16 (vs ₹0.34 in 2Q 2023)

Auro Laboratories Limited to Report Q2, 2024 Results on Nov 09, 2023

Auro Laboratories Limited Announces the Resignation of Amit Mahipat Shah as Chief Financial Officer, Effective October 1, 2023

Auro Laboratories Limited Appoints Vishal Kailashchandra Jhunjhunwala as an Non-Executive & Independent Director

Less than half of directors are independent

Auro Laboratories Limited, Annual General Meeting, Sep 23, 2023

Auro Laboratories Limited Announces Resignation of Govardhan Das Agarwal as Director

First quarter 2024 earnings released: EPS: ₹1.14 (vs ₹0.13 in 1Q 2023)

Auro Laboratories Limited to Report Q1, 2024 Results on Jul 31, 2023

Full year 2023 earnings released: EPS: ₹3.92 (vs ₹4.56 in FY 2022)

Investor sentiment improves as stock rises 23%

Investor sentiment improves as stock rises 16%

Third quarter 2023 earnings released: EPS: ₹0.59 (vs ₹0.98 in 3Q 2022)

Auro Laboratories Limited to Report Q3, 2023 Results on Feb 13, 2023

Second quarter 2023 earnings released: EPS: ₹0.34 (vs ₹1.14 in 2Q 2022)

Auro Laboratories Limited to Report Q2, 2023 Results on Nov 14, 2022

First quarter 2023 earnings released: EPS: ₹0.13 (vs ₹1.71 in 1Q 2022)

Auro Laboratories Limited to Report Q1, 2023 Results on Aug 02, 2022

Investor sentiment improved over the past week

Full year 2022 earnings released: EPS: ₹4.56 (vs ₹11.52 in FY 2021)

Auro Laboratories Limited Announces Management Changes

Auro Laboratories Limited to Report Q4, 2022 Results on May 30, 2022

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Whole Time Director recently bought ₹86k worth of stock

Investor sentiment deteriorated over the past week

First quarter 2022 earnings released: EPS ₹1.71 (vs ₹2.22 in 1Q 2021)

Investor sentiment improved over the past week

Full year 2021 earnings released: EPS ₹11.52 (vs ₹6.51 in FY 2020)

Investor sentiment improved over the past week

Auro Laboratories Limited Appoints Mrs. Kavita Sharma as Independent Director

Auro Laboratories Limited to Report Q3, 2021 Results on Feb 11, 2021

Investor sentiment improved over the past week

New 90-day high: ₹98.80

Second quarter 2021 earnings released: EPS ₹3.62

Market bids up stock over the past week

Auro Laboratories Limited to Report Q2, 2020 Results on Nov 05, 2020

New 90-day high: ₹67.65

New 90-day high - ₹58.10

First quarter earnings released

Auro Laboratories Limited to Report Q1, 2021 Results on Aug 31, 2020

New 90-day high - ₹52.25

CEO 보상 분석

CEO

테뉴어

보상

이사회 구성원

평균 재임 기간

평균 연령